Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 138 pages
Exam (elaborations)

BSN HESI 315 Pharmacology Exam V2 EXAM QUESTIONS AND CORRECT VERIFIED SOLUTIONS LATEST UPDATE THIS YEAR – JUST RELEASED.pdf

Document preview thumbnail
Preview 4 out of 138 pages

Tap on AVAILABLE IN BUNDLE/PACKAGE DEAL to unlock free bonus exams – save more while you get what you need. The BSN HESI 315 Pharmacology Exam V2 Questions and Correct Verified Solutions – Latest Updated Edition is a comprehensive and structured study resource designed to help nursing students prepare for BSN 315 Pharmacology Exam V2 and strengthen their understanding of medication-related concepts commonly assessed in HESI-style nursing examinations. Recent listings for the BSN HESI 315 Pharmacology V2 resource describe coverage of medication-specific nursing questions and updated 2026/2027 preparation material. This in-depth preparation resource covers major pharmacology areas, including pharmacokinetics and pharmacodynamics, medication classifications, mechanisms of action, therapeutic uses, contraindications, adverse effects, drug interactions, medication administration, patient education, nursing assessments, laboratory monitoring, dosage considerations, and safe medication practices. The material includes exam-style questions and solution explanations designed to reinforce clinical pharmacology knowledge. Learners will review scenarios involving cardiovascular medications, antihypertensives, diuretics, anticoagulants, antiarrhythmics, antibiotics, respiratory medications, endocrine and diabetic therapies, neurologic and psychiatric medications, gastrointestinal agents, analgesics, anti-inflammatory drugs, and medications requiring careful laboratory or adverse-effect monitoring. HESI pharmacology preparation commonly emphasizes medication administration, drug classifications, adverse effects, pharmacokinetics, dosage calculations, patient teaching, and priority nursing interventions. Special emphasis is placed on priority nursing assessments, high-risk medication precautions, adverse-effect recognition, therapeutic drug monitoring, contraindications, drug interactions, patient teaching, medication safety, and clinical decision-making. The resource is structured to encourage application of pharmacology knowledge to patient-care situations rather than relying solely on memorization. Key review areas include digoxin and cardiac medications, diuretics and electrolyte abnormalities, anticoagulants, antidepressants, antidiabetic medications, antihypertensives, antimicrobials, respiratory medications, pain medications, and other commonly tested pharmacologic agents. A recent BSN 315 V2 listing, for example, includes clinical questions involving furosemide-associated hypokalemia, illustrating the emphasis on recognizing adverse effects and selecting appropriate nursing assessments. The resource also reinforces safe medication administration, dosage and calculation principles, medication reconciliation, patient education, monitoring parameters, therapeutic response, adverse-reaction identification, and appropriate nursing interventions. Current HESI pharmacology preparation resources similarly emphasize medication safety and priority-based clinical reasoning. Aligned with BSN-level pharmacology concepts and HESI-style nursing assessment objectives, this study guide supports preparation in pharmacologic principles, medication administration, adverse effects, drug interactions, clinical monitoring, patient teaching, medication safety, and nursing interventions. Ideal for BSN 315 nursing students, HESI Pharmacology candidates, undergraduate nursing students, and learners preparing for Pharmacology Exam V2, this resource provides focused review materials, exam-style practice questions, and solution explanations to support effective studying and stronger pharmacology knowledge.

Content preview

Page 1 of 138



BSN HESI 315 Pharmacology Exam V2 EXAM QUESTIONS AND
CORRECT VERIFIED SOLUTIONS LATEST UPDATE THIS YEAR –
JUST RELEASED
BSN HESI 315 Pharmacology Exam V2
10-Line Exam Coverage in Points Form
1. Cardiovascular Medications – Digoxin toxicity (hypokalemia potentiates, nausea/visual
disturbances/arrhythmias, hold for apical pulse <60 bpm, therapeutic level 0.8-2.0
ng/mL) , heparin (aPTT monitoring, 1.5-2.5x control therapeutic, protamine sulfate
antidote) , warfarin (INR target 2-3, vitamin K antidote) , nitroglycerin sublingual (three
tablets q5min, maximum three doses) , amlodipine (blood pressure monitoring for
effectiveness) , metoprolol (hold if pulse <60, asthma/COPD caution) , atorvastatin
(muscle pain/tenderness reporting, CK monitoring) .
2. Anticoagulant & Antiplatelet Therapy – Clopidogrel (hold 5-7 days before surgery,
P2Y12 inhibitor) , enoxaparin (subcutaneous injection with air bubble retention, no
aspiration) , protamine sulfate (heparin reversal), vitamin K (warfarin reversal) .
3. Endocrine & Metabolic Medications – Insulin lispro (Humalog) rapid-acting (onset 15
min, peak 1 hour, administer with meals) , metformin (GI side effects minimized with
food, contraindicated in renal impairment due to lactic acidosis risk) , levothyroxine
(morning administration on empty stomach, signs of hyperthyroidism indicate
overdose) , spironolactone (potassium-sparing diuretic, avoid potassium-rich foods) .
4. Anti-infective Agents – Tetracycline (avoid dairy products, use sun protection, oral
candidiasis risk) , gentamicin (monitor peak/trough, nephrotoxicity, ototoxicity) ,
vancomycin (trough monitoring 10-20 mcg/mL, nephrotoxicity, ototoxicity) , TMP-
SMX/Bactrim (synergistic combination to reduce resistance, increase fluids to prevent
crystalluria) , ciprofloxacin (tendonitis/tendon rupture risk - black box warning) .
5. Neurological & Psychiatric Medications – Haloperidol (EPS symptoms like jaw
tightness/stiff neck, treat with diphenhydramine) , metoclopramide (extrapyramidal
symptoms monitoring) , clonazepam (slurred speech side effect, avoid alcohol) ,
rivastigmine (Alzheimer's treatment, insomnia side effect) , phenelzine (MAOI, tyramine-
restricted diet for hypertensive crisis prevention) .
6. Pain Management & Emergency Medications – Naloxone (opioid overdose reversal,
administer if comatose) , fentanyl (respiratory depression assessment) , morphine PCA
pump (two-nurse verification, wasting controlled substances) , acetaminophen toxicity
treatment with acetylcysteine , NSAIDs (GI bleeding risk assessment) .
7. Respiratory & Gastrointestinal Pharmacology – Theophylline (therapeutic range 10-20
mcg/mL, toxicity >22 mcg/mL) , albuterol (short-acting beta-2 agonist) , metronidazole

, Page 2 of 138


(avoid alcohol, disulfiram-like reaction) , cimetidine (take 1 hour after antacids, lethargy
requires evaluation) , misoprostol (check pregnancy status before administration) .
8. Medication Administration Safety – Five Rights of Medication Administration , enteric-
coated tablets (should not be crushed/chewed) , first-pass effect (hepatic metabolism
reduces bioavailability) , half-life determination (guides dosing intervals) , creatinine
clearance for renal dosing , synergy vs antagonism , Z-track IM injection technique .
9. Critical Adverse Effects & Monitoring – Hypokalemia (increases digoxin toxicity and
neuromuscular blockade risk) , ACE inhibitors (persistent dry cough, hyperkalemia) ,
methemoglobinemia (dizziness/palpitations with normal O₂ sat, treat with methylene
blue) , spironolactone (limit potassium-rich foods) , amiodarone (pulmonary toxicity
monitoring, hypotension/bradycardia) .
10. Patient Education & Nursing Interventions – Superinfection signs (oral soreness
indicates fungal infection) , antidiuretic hormone for diabetes insipidus (monitor serum
osmolality) , tamsulosin (alpha-blocker, sit/stand slowly to prevent orthostatic
hypotension) , bulk-forming laxatives (take with additional glass of water) , ribavirin
(monitor hemoglobin for anemia) , filgrastim (monitor white blood cell count for
effectiveness) .




250 MCQ Questions with Rationales




Question 1

The nurse determines that a theophylline level drawn yesterday was 22 mcg/mL. Based on this

information, which action should the nurse implement?

A) Hold the theophylline dose and notify the health care provider

B) Start the client on a half-dose of theophylline PO

C) The theophylline dose can be initiated as planned

D) The client is not ready to be weaned from the IV to the PO route


Correct Answer: A

, Page 3 of 138


Rationale: A theophylline level of 22 mcg/mL exceeds the therapeutic range of 10-20 mcg/mL

and indicates toxicity risk. The nurse must hold the dose and notify the provider to prevent

adverse effects such as cardiac arrhythmias or seizures . Initiating or reducing the dose without

provider guidance would be unsafe and could cause patient harm.




Question 2

The nurse is reviewing a client's laboratory results before a procedure in which a neuromuscular

blocking agent is a standing order. Which finding should the nurse report to the health care

provider?

A) Hypokalemia

B) Hyponatremia

C) Hypercalcemia

D) Hypomagnesemia


Correct Answer: A


Rationale: Hypokalemia increases the risk of adverse effects and prolonged neuromuscular

blockade when neuromuscular blocking agents are given. Electrolyte imbalances, especially low

potassium, affect nerve and muscle excitability and can lead to dangerous complications during

procedures requiring paralysis .

, Page 4 of 138


Question 3

The nurse is preparing a child for transport to the operating room for an emergency

appendectomy. The anesthesiologist prescribes atropine sulfate IM STAT. What is the primary

purpose for administering this drug to the child at this time?

A) Decrease the oral secretions

B) Reduce the child's anxiety

C) Potentiate the opioid effects

D) Prevent possible peritonitis


Correct Answer: A


Rationale: Atropine is an anticholinergic drug that is administered preoperatively to decrease

oral and respiratory secretions, reducing the risk of aspiration during anesthesia. While it may

have other effects, reducing secretions is the primary purpose in this scenario to maintain a

clear airway during surgery .




Question 4

When caring for a client on digoxin (Lanoxin) therapy, the nurse knows to be alert for digoxin

toxicity. Which finding would predispose this client to developing digoxin toxicity?

A) Low serum sodium level

B) High serum sodium level

C) Low serum potassium level

D) High serum potassium level

Document information

Uploaded on
August 11, 2026
Number of pages
138
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$30.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
surepass
4.9
(394)
Sold
6682
Followers
22
Items
3121
Last sold
10 hours ago


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions